Page results
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5- 8 patient information leaflet
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2022/0602 - Number of patients admitted for lung diseases over a five year period
-
FOI/2022/0606 - Breathing circuits supplier
-
FOI/2022/0608 - Patient experience feedback
-
FOI/2022/0609 - Parking for patents/ carers for children/ young people with cancer
-
FOI/2022/0611 - FTE staff, student staff, patients and attendances, bed numbers and occupancy
-
FOI/2022/0612 - Blood transfusions from patients vaccinated with mRNA gene therapy Coronavirus
-
FOI/2022/0615 - Vasectomy operations
-
FOI/2022/0616 - Corporate property and asset information facilities management
-
FOI/2022/0623 - Integration/ workflow solutions across multiple technology systems
-
FOI/2022/0625 - Lung cancer treatment